Post

India’s Serum Institute Manufactures Vaccines for U.S. Government

India’s Serum Institute Manufactures Vaccines for U.S. Government

Following on an approval from the USFDA,  Gaithersburg, Maryland-based biotechnology company Novavax said that its Covid-19 vaccine Nuvaxovid for adults will be manufactured by its partner Serum Institute of India. (SII)

“It is the first vaccine from India to be approved by the USFDA,” Serum Institute’s CEO Adar Poonawalla, said.

The Novavax Covid-19 vaccine is administered as a two-dose primary series, three weeks apart. The U.S. government has bought 3.2 million doses of this vaccine. In India, the same vaccine is branded as Covovax.

Chief Medical Officer of Novavax, Filip Dubovsky, said that all vaccines that are commercially distributed globally are made in a single facility by their partners, the Serum Institute of India. This includes the vaccines, which are being deployed around the world as well as the ones that will be initially deployed in the U.S.
SII and  Novavax are working on an Omicron variant-specific vaccine for Covid-19 that will be different from the original shot developed using the Wuhan strain of the Sars-CoV-2 virus.
Vaccine Production in SII
Share

About Amritt

Who We Are

Small or big, your business will love our financial help and business consultations! We are happy when our clients are too… Actually, this is quite simple to achieve – because each time we help them in sorting out different accounting intricacies or save the day before filing the taxes, they are happy indeed! And so are we.   

We have over Twenty years of experience helping our clients succeed in India

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Blog
Page
Dictionary
Comparisons
Capabilities
India Business Guide
Services
Private
Speaking
Insights
White Papers
News
Newsletters
Clients
Case Studies
Companies In India
Webinars
Presentations
Industries